News Headlines Article

Pharma Data Mining Restriction Options Available
Health Leaders Media

States that want to prevent drug companies from using physician prescribing practice data to market brand products should not be discouraged by a June 23 U.S. Supreme Court decision that struck down Vermont’s prohibition of the practice.

Rather, say authors of a paper in today’s New England Journal of Medicine, “clever lawmakers may, however, be able to write their way around the Court’s ruling” by passing laws that prohibit “untruthful or misleading statements in detailing conversations, since such speech receives no First Amendment protection. The District of Columbia has already enacted such a law.”